XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income $ 25,159,000 $ 27,833,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and impairment 3,902,000 5,016,000
Deferred income taxes (1,765,000) (120,000)
Reserve for uncertain tax positions 336,000 210,000
Non-cash share-based compensation expense 910,000 275,000
Loss on disposal of property and equipment 1,000 1,000
Net changes in assets and liabilities:    
Trade accounts receivable (1,655,000) (2,188,000)
Prepaid expenses and other current assets (97,000) 231,000
Deferred contract costs, net 988,000 318,000
Operating lease assets and liabilities, net (9,000) 17,000
Accounts payable (557,000) (207,000)
Accrued expenses, wages and bonuses 127,000 (202,000)
Income taxes receivable and payable 660,000 1,604,000
Deferred revenue 161,000 1,482,000
Net cash provided by operating activities 28,161,000 34,270,000
Cash flows from investing activities:    
Purchases of property and equipment (7,869,000) (3,797,000)
Acquisition consideration   (3,000,000)
Net cash used in investing activities (7,869,000) (6,797,000)
Cash flows from financing activities:    
Payments on notes payable (3,208,000) (3,049,000)
Payments on finance lease obligations (355,000) (369,000)
Proceeds from the exercise of share-based awards   304,000
Payment of employee payroll tax withholdings on share-based awards exercised (190,000) (461,000)
Repurchase of shares for treasury (25,299,000)  
Payments of deferred acquisition consideration (1,950,000)  
Payment of dividends on common stock (15,035,000) (6,105,000)
Net cash used in financing activities (46,037,000) (9,680,000)
Effect of exchange rate changes on cash and cash equivalents (224,000) (1,000)
Change in cash and cash equivalents (25,969,000) 17,792,000
Cash and cash equivalents at beginning of period 54,361,000 34,690,000
Cash and cash equivalents at end of period 28,392,000 52,482,000
Supplemental disclosure of cash paid for:    
Interest expense, net of capitalized amounts 1,028,000 1,186,000
Income taxes 8,947,000 6,601,000
Supplemental disclosure of non-cash investing and financing activities:    
Stock tendered to the Company for cashless exercise of stock options in connection with equity incentive plans $ 311,000 749,000
Deferred acquisition consideration   $ 1,950,000